Unknown NA INTERVENTIONAL 3-arm NCT05352113

Intradermal Needle Therapy for Major Depressive Disorder

Sponsor: The Affiliated Hangzhou First People's Hospital

Interventions SSRIs acupuncture placebo sham acupuncture

Updated 4 times since 2022 Last updated: Apr 27, 2022 Started: May 1, 2022 Primary completion: May 1, 2025 Completion: Dec 30, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05352113, this NA trial focuses on Major Depressive Disorder and remains ongoing. Sponsored by The Affiliated Hangzhou First People's Hospital, it has been updated 4 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Feb 2026 — Present [monthly]

Unknown NA

Status: Not Yet Recruiting → Unknown
Sep 2024 — Feb 2026 [monthly]

Not Yet Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting NA
May 2022 — Jul 2024 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

The Affiliated Hangzhou First People's Hospital
The Third Affiliated hospital of Zhejiang Chinese Medical University
The Zhejiang Provincial Tongde Hospital

Data source: The Third Affiliated hospital of Zhejiang Chinese Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hangzhou, China